MoneyWorks4Me

Jagsonpal Pharmaceuticals informs about compliance certificate

24 Jul 2019 Evaluate

In Compliance with Regulation 74(5) of SEBl (Depositories and Participants) Regulations, 2018, Jagsonpal Pharmaceuticals has informed that it has enclosed a copy of the Certificate received from MCS Share Transfer Agent, the Registrar and share Transfer Agent of the Company, for the quarter ended 30th June, 2019.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1840.00
Dr. Reddys Labs. 1222.50
Cipla 1388.90
Lupin 2061.85
Zydus Lifesciences 1212.00
View more..